3-Aug-2003 FDA CDER EES Page 3 of 3
ESTABLISHMENT EVALUATION REQUEST
DETAIL
SUBMITTED TO OC 27-SEP-2002 MCLAMORES
OC RECOMMENDATION 30-SEP-2002 ACCEPTABLE DAMBROGIOJ
BASED
ON PROFILE
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page